The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models
Kristian W. Pajtler(German Cancer Research Center), Johannes H. Schulte(German Cancer Society)
Cited by 44
Related Papers
ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
|Cancer Discovery|2021|90
Newborn Screening and Presymptomatic Treatment of Metachromatic Leukodystrophy
|New England Journal of Medicine|2024|20
Table S1 from ZFTA–RELA Dictates Oncogenic Transcriptional Programs to Drive Aggressive Supratentorial Ependymoma
|Unknown|2023|0
Single-cell multidimensional profiling of tumor cell heterogeneity in supratentorial ependymomas
|bioRxiv (Cold Spring Harbor Laboratory)|2024|0